Literature DB >> 10615848

Induced abortion and breast cancer risk.

D Lazovich1, J A Thompson, P J Mink, T A Sellers, K E Anderson.   

Abstract

Results from case-control studies suggest that induced abortion may be associated with a small increase in risk of breast cancer. While risk estimates from cohort studies have generally not observed such an association, these studies have had limited information regarding abortion and possible confounding variables. Therefore, we conducted a study among a cohort of post-menopausal women from whom detailed information regarding pregnancy outcomes as well as risk factors for breast cancer had been collected. The study sample included 37,247 Iowa Women's Health Study participants, 55-64 years of age at baseline in 1986, who reported no history of breast, or other, cancer (except non-melanoma skin cancer), and for whom information regarding pregnancy outcomes (that is, live birth, stillbirth, spontaneous abortion, ectopic pregnancy or induced abortion) was available. We used linkage with records of the State Health Registry of Iowa, part of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program, to estimate the incidence of breast cancer among cohort members through 1995. We calculated age-adjusted relative risks and 95% confidence intervals using Cox proportional hazards regression. Only 653 women (1.8%) reported an induced abortion. The age-adjusted relative risk of breast cancer among women with prior induced abortion compared with those without was 1.1 (95% CI = 0.8-1.6). Relative risks were higher among women whose age at first abortion was less than 20 or at least 30 years, for those whose abortion took place after their first birth or who never gave birth, and for those with early termination (0-2 months). These estimates varied from 1.3-1.7, but the confidence intervals around each were wide. Since most women in this cohort were beyond their reproductive years when abortion became legal in 1973, the low prevalence of induced abortion argues for a cautious interpretation.

Entities:  

Mesh:

Year:  2000        PMID: 10615848     DOI: 10.1097/00001648-200001000-00016

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  7 in total

1.  Abortion and breast cancer: a case-control record linkage study.

Authors:  M J Goldacre; L M Kurina; V Seagroatt; D Yeates
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

2.  Risk of breast cancer after miscarriage or induced abortion: a Scottish record linkage case-control study.

Authors:  David H Brewster; Diane L Stockton; Richard Dobbie; Diana Bull; Valerie Beral
Journal:  J Epidemiol Community Health       Date:  2005-04       Impact factor: 3.710

3.  Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women: a case-control study.

Authors:  Betul Oran; Ismail Celik; Mustafa Erman; Esmen Baltali; Nurullah Zengin; Figen Demirkazik; Sabahat Tezcan
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

4.  Breast cancer in relation to induced abortions in a cohort of Chinese women.

Authors:  Z Ye; D L Gao; Q Qin; R M Ray; D B Thomas
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

5.  Predictive Analysis of Palmar Dermatoglyphics in Patients with Breast Cancer for Small Bosnian-Herzegovinian Population.

Authors:  Azra Metovic; Jasmin Musanovic; Selma Alicelebic; Esad Pepic; Senad Sljuka; Maida Mulic
Journal:  Med Arch       Date:  2018-11

6.  Breast cancer risk factors in Turkish women--a University Hospital based nested case control study.

Authors:  Vahit Ozmen; Beyza Ozcinar; Hasan Karanlik; Neslihan Cabioglu; Mustafa Tukenmez; Rian Disci; Tolga Ozmen; Abdullah Igci; Mahmut Muslumanoglu; Mustafa Kecer; Atilla Soran
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

Review 7.  Informed consent in the (mis)information age.

Authors:  Erin L Nelson
Journal:  J Obstet Gynaecol Can       Date:  2004-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.